After spending 20 years at Novartis, Radiopharm Theranostics Ltd. CEO Riccardo Canevari told BioWorld that when he joined Radiopharm he wanted to focus on something different within ...
In a recent study published in the Proceedings of the National Academy of Sciences Journal, researchers examined the therapeutic effects of targeting integrins for treating Amyotrophic lateral ...
SAN DIEGO, APRIL 15, 2026 ― Researchers from The University of Texas MD Anderson Cancer Center will present initial data from six clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results